journal article·2023Open access

LipoParticles: a lipid membrane coating onto polymer particles to enhance the internalization in osteoblast cells

Florian Vanneste, Allison Faure, Mathieu Varache, Mario Menendez-Miranda, Virginie Dyon-Tafani, Sébastien Dussurgey, Elisabeth Errazuriz-Cerda, Veronica La Padula, Pierre Alcouffe, Marie Carrière, Ruxandra Gref, Frédéric Laurent, Jérôme Josse, Catherine Ladavière

Nanoscale· Volume 15· Issue 44

Abstract

LipoParticles, core-shell assemblies consisting of a polymer core coated by a lipid membrane, are promising carriers for drug delivery applications with intracellular targets. This is of great interest since it is actually challenging to treat infections involving intracellular bacteria such as bone and joint infections where the bacteria are hidden in osteoblast cells. The present work reports for the first time to the best of our knowledge the proof of enhanced internalization of particles in osteoblast cells thanks to a lipid coating of particles (= LipoParticles). The ca. 300 nm-sized assemblies were elaborated by reorganization of liposomes (composed of DPPC/DPTAP 10/90 mol/mol) onto the surface of poly(lactic-co-glycolic acid) (PLGA) particles, and were characterized by dynamic light scattering (DLS), transmission electron microscopy (TEM), and zetametry. Optimization of these assemblies was also performed by adding poly(ethylene glycol) (PEG) chains on their surface (corresponding to a final formulation of DPPC/DPTAP/DPPE-PEG5000 8/90/2 mol/mol/mol). Interestingly, this provided them colloidal stability after their 20-fold dilution in PBS or cell culture medium, and made possible their freeze-drying without forming aggregates after their re-hydration. Their non-cytotoxicity towards a human osteoblast cell line (MG63) was also demonstrated. The enhanced internalization of LipoParticles in this MG63 cell line, in comparison with PLGA particles, was proven by observations with a confocal laser scanning microscope, as well as by flow cytometry assays. Finally, this efficient internalization of LipoParticles in MG63 cells was confirmed by TEM on ultrathin sections, which also revealed localization close to intracellular Staphylococcus aureus.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Université de Lyon, CNRS, Université Claude Bernard Lyon 1, INSA Lyon, Université Jean Monnet, UMR 5223, Ingénierie des Matériaux Polymères F-69622 Cedex, France

Centre International de Recherche en Infectiologie (CIRI), Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France

Institut de Sciences Moléculaires d'Orsay (ISMO), Univ. of Paris-Sud, Orsay 91405, France

Structure Fédérative de Recherche Biosciences, UMS344/US8, Inserm, CNRS, Université Claude Bernard Lyon-1, ENS de Lyon, Lyon, France

Centre d'Imagerie Quantitative Lyon-Est (CIQLE), Université Claude Bernard Lyon 1, Lyon, France

Centre Technologique des Microstructures, Université Claude Bernard Lyon 1, Villeurbanne, France

Université Grenoble-Alpes, CEA, CNRS, IRIG, SyMMES, CIBEST, 38000 Grenoble, France

Funding

Agence Nationale de la Recherche

References (67)

Show source-provided references
1. Tande · Clin. Microbiol. Rev. · 2014 · 27 · 30210.1128/CMR.00111-13 ↗
2. Josse · Front. Cell. Infect. Microbiol. · 2015 · 5 · 8510.3389/fcimb.2015.00085 ↗
3. Marro · J. Antimicrob. Chemother. · 2021 · 76 · 309110.1093/jac/dkab301 ↗
4. Shukla · Cell · 2023 · 186 · 405910.1016/j.cell.2023.07.038 ↗
5. Patra · J. Nanobiotechnol. · 2018 · 16 · 7110.1186/s12951-018-0392-8 ↗
6. Caster · Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. · 2017 · 9 · e1416
7. Ventola · P & T : a peer-reviewed journal for formulary management · 2017 · 42 · 742
8. Guimarães · Int. J. Pharm. · 2021 · 601 · 12057110.1016/j.ijpharm.2021.120571 ↗
9. Liu · Molecules · 2022 · 27 · 137210.3390/molecules27041372 ↗
10. Large · Adv. Drug Delivery Rev. · 2021 · 176 · 11385110.1016/j.addr.2021.113851 ↗
11. G.Barratt , G.Couarraze , P.Couvreur , C.Dubernet , E.Fattal , R.Gref , D.Labarre , P.Legrand , G.Ponchel and C.Vauthier , Polymeric Micro- and Nanoparticles as Drug Carriers , in Polymeric Biomaterials, Revised and Expanded , ed. S. Dumitriu , CRC Press , 2001
12. El-Say · Int. J. Pharm. · 2017 · 528 · 67510.1016/j.ijpharm.2017.06.052 ↗
13. Elmowafy · J. Pharm. Invest. · 2019 · 49 · 34710.1007/s40005-019-00439-x ↗
14. Danhier · J. Controlled Release · 2012 · 161 · 50510.1016/j.jconrel.2012.01.043 ↗
15. Yoo · ACS Biomater. Sci. Eng. · 2020 · 6 · 605310.1021/acsbiomaterials.0c01228 ↗
16. Park · J. Controlled Release · 2019 · 304 · 12510.1016/j.jconrel.2019.05.003 ↗
17. Alsaab · Pharmaceutics · 2022 · 14 · 272810.3390/pharmaceutics14122728 ↗
18. Troutier · Adv. Colloid Interface Sci. · 2007 · 133 · 110.1016/j.cis.2007.02.003 ↗
19. Thevenot · Biomacromolecules · 2007 · 8 · 365110.1021/bm700753q ↗
20. Thevenot · J. Phys. Chem. B · 2008 · 112 · 1381210.1021/jp805865r ↗
21. Troutier · Langmuir · 2005 · 21 · 130510.1021/la047659t ↗
22. Troutier · Langmuir · 2005 · 21 · 990110.1021/la050796l ↗
23. Bathfield · Macromolecules · 2008 · 41 · 834610.1021/ma801567c ↗
24. Troutier-Thuilliez · Soft Matter · 2009 · 5 · 473910.1039/b911260j ↗
25. Lacour · Adv. Healthcare Mater. · 2016 · 5 · 203210.1002/adhm.201600091 ↗
26. Bugnicourt · J. Controlled Release · 2017 · 256 · 12110.1016/j.jconrel.2017.04.018 ↗
27. Bugnicourt · J. Colloid Interface Sci. · 2019 · 534 · 10510.1016/j.jcis.2018.08.098 ↗
28. Provost · Sci. Rep. · 2019 · 9 · 1796710.1038/s41598-019-53528-0 ↗
29. Ayad · Pharmaceutics · 2021 · 13 · 37710.3390/pharmaceutics13030377 ↗
30. Messerschmidt · J. Controlled Release · 2009 · 137 · 6910.1016/j.jconrel.2009.03.010 ↗
31. Sengupta · Nature · 2005 · 436 · 56810.1038/nature03794 ↗
32. Bershteyn · Soft Matter · 2008 · 4 · 178710.1039/b804933e ↗
33. Tan · Nanoscale · 2013 · 5 · 86010.1039/c2nr32880a ↗
34. Persano · Nano Express · 2021 · 2 · 01200610.1088/2632-959X/abeb4b ↗
35. Krishnamurthy · Biomater. Sci. · 2015 · 3 · 92310.1039/C4BM00427B ↗
36. Mandal · Nanomedicine · 2013 · 9 · 47410.1016/j.nano.2012.11.010 ↗
37. Ma · Colloids Surf., B · 2014 · 117 · 51210.1016/j.colsurfb.2014.02.039 ↗
38. M. Ö.Öztürk Öncel , B.Garipcan and F.Inci , Biomedical Applications: Liposomes and Supported Lipid Bilayers for Diagnostics, Theranostics, Imaging, Vaccine Formulation, and Tissue Engineering , in Biomimetic Lipid Membranes: Fundamentals, Applications, and Commercialization , ed. F. N. Kök , A. Arslan Yildiz and F. Inci , Springer International Publishing , Cham , 2019 , pp. 193–21210.1007/978-3-030-11596-8_8 ↗
39. Nsairat · Heliyon · 2022 · 8 · e0939410.1016/j.heliyon.2022.e09394 ↗
40. Chan · Proc. Natl. Acad. Sci. U. S. A. · 2010 · 107 · 221310.1073/pnas.0914585107 ↗
41. Yi · Nanoscale Res. Lett. · 2014 · 9 · 56010.1186/1556-276X-9-560 ↗
42. Hitzman · J. Pharm. Sci. · 2006 · 95 · 111410.1002/jps.20591 ↗
43. Li · Int. J. Nanomed. · 2012 · 7 · 187
44. Li · Front. Bioeng. Biotechnol. · 2020 · 8 · 102710.3389/fbioe.2020.01027 ↗
45. Mornet · Nano Lett. · 2005 · 5 · 28110.1021/nl048153y ↗
46. Jadon · J. Drug Delivery Sci. Technol. · 2019 · 51 · 47510.1016/j.jddst.2019.03.039 ↗
47. Harush-Frenkel · Biomacromolecules · 2008 · 9 · 43510.1021/bm700535p ↗
48. Liu · J. Am. Chem. Soc. · 2009 · 131 · 135410.1021/ja808018y ↗
49. Shi · Int. J. Nanomed. · 2012 · 5593
50. Corsi · Biomaterials · 2003 · 24 · 125510.1016/S0142-9612(02)00507-0 ↗
51. Xu · RSC Adv. · 2014 · 4 · 4648110.1039/C4RA06863G ↗
52. Cenni · J. Biomater. Sci., Polym. Ed. · 2012 · 1
53. Rabinovich · MRS Proc. · 2007 · 1019 · 50610.1557/PROC-1019-FF05-06 ↗
54. Wang · Int. J. Nanomed. · 2015 · 10 · 5671
55. Bangham · J. Mol. Biol. · 1965 · 13 · 23810.1016/S0022-2836(65)80093-6 ↗
56. Pancani · Part. Part. Syst. Charact. · 2018 · 35 · 170045710.1002/ppsc.201700457 ↗
57. Bourguignon · Int. J. Pharm. · 2021 · 610 · 12120210.1016/j.ijpharm.2021.121202 ↗
58. Abdelwahed · Adv. Drug Delivery Rev. · 2006 · 58 · 168810.1016/j.addr.2006.09.017 ↗
59. Shulkin · J. Microencapsulation · 1984 · 1 · 7310.3109/02652048409031539 ↗
60. Stark · Eur. J. Pharm. Sci. · 2010 · 41 · 54610.1016/j.ejps.2010.08.010 ↗
61. van den Hoven · Int. J. Pharm. · 2012 · 438 · 20910.1016/j.ijpharm.2012.08.046 ↗
62. Chaudhury · Int. J. Pharm. · 2012 · 430 · 16710.1016/j.ijpharm.2012.04.036 ↗
63. Vega · Int. J. Nanomed. · 2012 · 135710.2147/IJN.S28481 ↗
64. Alshehri · Sci. Rep. · 2018 · 8 · 374810.1038/s41598-018-22166-3 ↗
65. Un · Biomaterials · 2012 · 33 · 813110.1016/j.biomaterials.2012.07.030 ↗
66. Przybylo · Eur. J. Pharm. Sci. · 2016 · 85 · 3910.1016/j.ejps.2016.01.028 ↗
67. Braun · Cytometry, Part A · 2016 · 89 · 30110.1002/cyto.a.22792 ↗